A quick question for the technically minded.
Can anyone explain why the burn rate for the phase III
study is so high?
On googling, I note that the average cost per patient for a typical phase III is $26,000
(see here) http://www.lifesciencesworld.com/news/view/11080
If ATC patient total for ph.3 is 39, my back of the envelope cost for the study is $1,014,000
Where does the extra $10m+ expended?
Just curious.
Add to My Watchlist
What is My Watchlist?